Dr. Lam Tai Chung - Clinical Oncology
Highlights
- MCHK RegisteredVerified
- Specialist in Clinical OncologyBachelor of Medicine and Bachelor of Surgery (MBBS) · Hong Kong College of Radiologists · Medical degree 2003
- InsuranceBeing compiled｜See details
About
Dr. Lam Tai Chung is a registered Clinical Oncology specialist in Hong Kong.
Education
- Bachelor of Medicine and Bachelor of Surgery (MBBS)Bachelor of Medicine and Bachelor of Surgery (MBBS)2003
- FHKCRFellow, Hong Kong College of Radiologists
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Insurance
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Lam Tai Chung? Claim page and update insurance →
FAQ
Research and publications
30 papers · 12 most recent shown
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- Health-related quality-of-life of WHO grade 4 astrocytoma patients receiving alternating electrical field therapy: a prospective real-world multi-centre study.Journal of neuro-oncology · 2026
- Impact of alternating electric fields therapy for newly diagnosed WHO grade 4 astrocytoma on patient survival: a real-world propensity-score adjusted prospective multicenter study.Journal of neuro-oncology · 2025
- Comparative effect of Tai Chi and aerobic exercise on cognitive function in advanced lung cancer survivors with perceived cognitive impairment: a three-arm randomized controlled trial with mediation analysis.Journal of cancer survivorship : research and practice · 2025
- Pre-existing CD95-based Temra immunity in patients with recurrent/metastatic nasopharyngeal carcinoma predicts response and hyperprogression to dual PD-L1 and TGFβ inhibition.Clinical and translational medicine · 2025
- Effectiveness of Aerobic Exercise and Tai Chi Interventions on Sleep Quality in Patients With Advanced Lung Cancer: A Randomized Clinical Trial.JAMA oncology · 2024
- Tai Chi and Aerobic Exercise on Cancer-Related Dyspnea in Advanced Lung Cancer Patients: A Randomized Clinical Trial.Journal of pain and symptom management · 2024
- Bone-targeting agents in major solid tumour metastases: a multinational cohort study.BMJ supportive & palliative care · 2024
- Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trial.The lancet. Gastroenterology & hepatology · 2023
- Patterns of care and survival of Chinese glioblastoma patients in the temozolomide era: a Hong Kong population-level analysis over a 14-year period.Neuro-oncology practice · 2023
- The impact of the multi-disciplinary molecular tumour board and integrative next generation sequencing on clinical outcomes in advanced solid tumours.The Lancet regional health. Western Pacific · 2023
- Tumour mutational burden is overestimated by target cancer gene panels.Journal of the National Cancer Center · 2023
- Consensus Statements on Precision Oncology in the China Greater Bay Area.JCO precision oncology · 2023
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
Elsewhere on the web
These links are matched automatically by the doctor's name and are not confirmed by the doctor. Names repeat in Hong Kong — open a link to check.
For reference only. Not medical advice. Read full disclaimer